Targeted nanoparticles enhanced flow electroporation of antisense oligonucleotides in leukemia cells

Biosensors and Bioelectronics

Volumn 26, Issue 2, 2010, Pages 778-783

  Wang, Shengnian ^a   Zhang, Xulang ^b   Yu, Bo ^b,c   Lee, Robert J ^b,d   Lee, L James ^b,c  

^a LOUISIANA TECH UNIVERSITY   (United States)

^b NSF Center for Affordable Nanoengineering of Polymer Biomedical Devices (CANPBD)   (United States)

^c Ohio State University   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Antisense ODN; Electroporation; Gene delivery; Lipoplex; Microfluidics

Indexed keywords

ANTISENSE; ANTISENSE OLIGONUCLEOTIDES; CELL VIABILITY; CHRONIC MYELOID LEUKEMIAS; ELECTRIC PULSE; ELECTROPORATION; GENE DELIVERY; IN-VITRO; K562 CELLS; LEUKEMIA CELLS; LIPOPLEXES; NON-TARGETED; SEMI-CONTINUOUS; TARGETED NANOPARTICLE;

CELL CULTURE; DISEASES; GENE TRANSFER; MICROFLUIDICS; OLIGONUCLEOTIDES;

NANOPARTICLES;

LIPOSOME; NANOPARTICLE; OBLIMERSEN; TRANSFERRIN RECEPTOR;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE TRANSPORT; CELL STRAIN K 562; CELL VIABILITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG TARGETING; ELECTROPORATION; ENCAPSULATION; ENDOCYTOSIS; LEUKEMIA CELL; MICROFLUIDICS; SEMI CONTINUOUS FLOW ELECTROPORATION;

DNA, ANTISENSE; ELECTROPORATION; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FLOW INJECTION ANALYSIS; GENE TARGETING; HUMANS; K562 CELLS; TRANSFECTION;

EID: 77956923747     PISSN: 09565663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bios.2010.06.025     Document Type: Article

References (39)

1. Abdallah B., Hassan A., Benoist C., Goula D., Behr J.P., Demeneix B.A. Hum. Gene Ther. 1996, 7:1947-1954.
2. Allen T.M., Sapra P., Moase E. Cell Mol. Biol. Lett. 2002, 7:889-894.
3. Boussif O., Zanta M.A., Behr J.P. Gene Ther. 1996, 3:1074-1080.
4. Chang D.C., Chassy B.M., Saunder J.A. Guide to Electroporation and Electrofusion 1992, Academic, San Diego.
5. Chiu S.J., Liu S.J., Perrotti D., Marcucci G., Lee R.J. J. Controlled Release 2006, 112:199-207.
6. Fei Z., Wang S., Xie Y., Brian H., Koh C., Lee L.J. Anal. Chem. 2007, 79:5719-5722.
7. Felgner P.L., Barenholz Y., Behr J.P., Cheng S.H., Cullis P., Huang L., Jessee J.A., Seymour L., Szoka F., Thierry A.R., Wagner E., Wu G. Hum. Gene Ther. 1997, 8:511-512.
8. Gehl J. Acta Physiol. Scand. 2003, 177:437-447.
9. Hamer D.H., Leder P. Cell 1979, 18:1299-1302.
10. Hamm A., Krott N., Breibach I., Blindt R., Bosserhoff A.K. Tissue Eng. 2002, 8:235-245.
11. Huang Y., Rubinsky B. Biomed. Microdev. 1999, 2:145-150.
12. Huang Y., Rubinsky B. Sens. Actuators A 2001, 89:242-249.
13. Jeffs L.B., Palmer L.R., Ambegia E.G., Giesbrecht C., Ewanick S., Maclachlan I. Pharm. Res. 2005, 22:362-372.
14. Khine M., Lau A., Ionescu-Zanetti C., Seo J., Lee L.P. Lab Chip 2005, 5:38-43.
15. Kim J., Cho K., Shin Y., Jung N., Chung C., Chang J. Biosens. Bioelectron. 2007, 22:3273-3277.
16. Li S., Ma Z. Curr. Gene Ther. 2001, 1:201-226.
17. Lin Y.C., Jen C.M., Huang M.Y., Wu C.Y., Lin X.Z. Sens. Actuators B 2001, 79:137-143.
18. Lorenz P., Harnack U., Morgenstern R. Biotechnol. Lett. 2004, 26:1589-1592.
19. Lu H., Schmidt M.A., Jensen K.F. Lab Chip 2005, 5:23-29.
20. Lungwitz U., Breunig M., Blunk T., Gopferich A. Eur. J. Pharm. Biopharm. 1996, 3:137-144.
21. Marshall E. Science 1999, 286:2244-2245.
22. Mcclain M.A., Culbertson C.T., Jacobson S.C., Allbritton N.L., Sims C.E., Ramsey J.M. Anal. Chem. 2003, 75:5646-5655.
23. Mulligan R.C., Howard B.H., Berg P. Nature 1979, 277:108-111.
24. Neumann E., Schaefer-Ridder M., Wang Y., Hofschneider P.H. EMBO J. 1982, 1:841-845.
25. Neumann E., Kakorin S. Radiol. Oncol. 1998, 32:7-17.
26. Sato Y., Yamauchi N., Takahashi M., Sasaki K., Fukaura J., Neda H., Fujii S., Hirayama M., Itoh Y., Koshita Y., Kogawa K., Kato J., Sakamaki S., Niitsu Y. FASEB J. 2000, 14:2108-2118.
27. Schakowski F., Buttgereit P., Mazur M., Marten A., Schottker B., Gorschluter M., Schmidt-Wolf I. Generic Vaccine Ther. 2004, 2:1-11.
28. Schmid R.M., Weidenbach H., Draenert G.F., Liptay S., Luhrs H., Adler G. Gut 1997, 41:549-556.
29. Skelley A.M., Kirak O., Suh H., Jaenisch R., Voldman J. Nat. Methods 2009, 6:147-152.
30. Teissie J., Rols M.P. Biophys. J. 1993, 65:409-413.
31. Gene and Cell Therapy: Therapeutic Mechanism and Strategies 2004, Marcel Dekker, New York. second ed. N.S. Templeton (Ed.).
32. Toneguzzo F., Keating A. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:3496-3499.
33. Verma I.M., Somia N. Nature 1997, 389:239-242.
34. Wang H., Lu C. Anal. Chem. 2006, 78:5158-5164.
35. Wang S., Zhang X., Wang W., Lee L.J. Anal. Chem. 2009, 81:4414-4421.
36. Weecharangsan W., Opanasopit P., Lee R.J. Anticancer Res. 2007, 27:309-314.
37. Gao X., Huang L. Biochemistry 1996, 35:1027-1036.
38. Xu L.A., Pirollo K.F., Tang W.H., Rait A., Chang E.H. Hum. Gene Ther. 1999, 10:2941-2952.
39. Yang X., Koh C.-G., Liu S., Pan X., Santhanam R., Yu B., Peng Y., Pang J., Golan S., Talmon Y., Jin J., Muthusamy N., Byrd J.C., Chan K.K., Lee L.J., Marcucci G., Lee R.J. Mol. Pharm. 2009, 6:221-230.